Searched over 200M research papers
10 papers analyzed
These studies suggest that NMN supplementation has various potential benefits, including improving cognitive function, promoting anti-aging changes, enhancing energy metabolism, and providing cardioprotection, though further clinical investigations are needed to confirm its effectiveness and safety.
12 papers analyzed
19 papers analyzed
Nicotinamide mononucleotide (NMN) is a precursor to nicotinamide adenine dinucleotide (NAD+), a critical coenzyme in cellular metabolism. NAD+ levels naturally decline with age, contributing to various age-related pathologies. NMN supplementation has been proposed as a method to restore NAD+ levels and counteract these effects.
Research has shown that NMN supplementation can significantly improve cognitive function in aged mice by enhancing neurovascular coupling (NVC) responses. In a study, 24-month-old mice treated with NMN for two weeks exhibited improved cerebral blood flow and endothelial function, which were associated with better spatial working memory and gait coordination. This suggests that NMN can mitigate age-related cognitive decline by restoring NAD+ levels and improving vascular health.
NMN has also been found to promote an anti-aging microRNA (miRNA) expression profile in the aorta of aged mice. This change in miRNA expression is linked to improved endothelial function, reduced oxidative stress, and potential anti-atherogenic effects. These findings highlight NMN's role in vascular rejuvenation and its potential to prevent age-related vascular diseases.
Long-term NMN administration has been shown to mitigate various age-associated physiological declines. In a 12-month study, NMN supplementation in mice led to reduced body weight gain, enhanced energy metabolism, improved insulin sensitivity, and better plasma lipid profiles. Additionally, NMN improved mitochondrial function and gene expression related to metabolism. These results underscore NMN's potential as a comprehensive anti-aging intervention.
NMN has demonstrated significant effects on glucose metabolism, particularly in the context of Type 2 Diabetes. NMN treatment enhances glucose uptake and utilization in muscle tissue, liver, and adipose tissue, contributing to improved metabolic health. Interestingly, NMN also induces metabolic rewiring in the brain, promoting ketone body production and fasting-associated effects.
While NMN is generally considered beneficial, high doses have been shown to promote ferroptosis and suppress lung adenocarcinoma growth through the NAM-mediated SIRT1–AMPK–ACC pathway. This suggests that NMN's effects can vary significantly depending on the dosage and context, highlighting the need for careful consideration in clinical applications.
NMN has been found to offer cardioprotective benefits, particularly against ischemia-reperfusion (IR) injury. NMN stimulates glycolysis, leading to enhanced ATP synthesis and acidosis during reperfusion, which are protective mechanisms for the heart. These effects are partly independent of the SIRT1 pathway, suggesting multiple mechanisms of action.
NMN also plays a role in maintaining intestinal homeostasis by modulating gut microbiota. Long-term NMN treatment increases the abundance of beneficial bacteria and reduces harmful bacteria, improving intestinal barrier function and reducing mucosal permeability. These effects contribute to overall gut health and may have broader implications for systemic health.
Nicotinamide mononucleotide (NMN) shows promise as an anti-aging intervention with multifaceted benefits, including improved cognitive function, vascular health, metabolic regulation, and gut health. However, the effects of NMN can vary based on dosage and context, particularly in cancer treatment. Further clinical studies are needed to fully understand NMN's therapeutic potential and safety in humans.
Most relevant research papers on this topic